MENU
CELU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Celularity (CELU) Ownership - Who owns Celularity?
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases... Show more
Profile
Industry
N/A
Address
170 Park Avenue
Phone
+1 908 768-2170
Employees
225
Web
https://www.celularity.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
58.45M
P/E Ratio
N/A
Total Cash
863K
Projected Growth
N/A
Total Debt
70.15M
Revenue
44.59M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
1.94 USD as % of share price
Fundamentals
CELU
Capitalization
58.5M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
863K
Total Cash/Share
0.03
Total Debt
70.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.94%
Revenue
44.6M
ROE
N/A
Book Value
-25.5M
P/B Ratio
10.67
Cash Flow
N/A
Earnings
-3.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
0.25
Current Revenue Per Employee
46634.14
Dividends Per Share - Security
N/A
EBITDA
-58.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.61
Revenue To Assets
-57.60
Shares Held By Institutions
5.3M
Shares Outstanding - Current
26.7M
Total Liabilities
146M
Total Volume MTD
N/A
Value
N/A
Gain YTD
3.365
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a blank check company, which focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
170 Park Avenue
Phone
+1 908 768-2170
Employees
225
Web
https://www.celularity.com